UnknownNot Applicable

Mid-Infrared Spectroscopy as a Real Time Diagnostic Tool for Chronic Endometritis

Israel120 participantsStarted 2019-12-12

Plain-language summary

The Investigator propose to develop an in-vitro technique for the measurement and analysis of freshly excised biopsies during hysteroscopy procedure in patients with suspected Chronic Endometritis (CE) condition. Furthermore, the investigator propose to develop a discrimination model between the CE and inflammatory CE types using the measured spectroscopic data from freshly excised biopsies.

Who can participate

Age range18 Years – 45 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients scheduled to undergo hysteroscopy for the evaluation of abnormal bleeding or abnormal cervical or uterine findings. * Patients scheduled for any histological evaluation including endometrial biopsy, dilatation and curettage (D\&C), biopsy/excision of uterine polyp or fibroid or any other cervical or uterine lesion. * Age 18 and over. Exclusion Criteria: * Pregnant women, minors and lack of judgment women will not included * At the request of the examined woman

What they're measuring

Comparison of infrared spectroscopy (ATR-FTIR technique) with routine histopathology

Timeframe: 2 Years

Trial details

NCT IDNCT04197167

SponsorHillel Yaffe Medical Center

Sponsor typeOTHER_GOV

Study typeINTERVENTIONAL

Primary completion2022-12-31

Contact for this trial

Einat Shalom-Paz, Prof

+972-47744750 EinatS@hy.health.gov.il

View on ClinicalTrials.gov More Endometritis trials